Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Ladoire

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Bulletin Du Cancer|November 9, 2019
[Strategies in case of metastatic sentinel lymph node in breast cancer]Hélène Costaz, Magali Rouffiac, Delphine Boulle, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsFrançois Ghiringhelli, Cedric Menard, Pierre Emmanuel Puig, et al.
British Journal of Cancer|July 18, 2020
Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based studyJulien Simon, Marie Chaix, Oumar Billa, et al.
Cancers|June 19, 2024
HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular EntityCéline André, Aurélie Bertaut, Sylvain Ladoire, et al.
Oncotarget|January 30, 2016
Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?Valentin Derangère, Jean David Fumet, Romain Boidot, et al.
Cancers|November 11, 2022
Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune CheckpointsDelphine Hudry, Solenn Le Guellec, Samuel Meignan, et al.
BMC Infectious Diseases|December 6, 2008
Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patientsPierre Emmanuel Charles, Sylvain Ladoire, Aurélie Snauwaert, et al.
Breast Cancer Research and Treatment|March 16, 2010
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapySylvain Ladoire, Laurent Arnould, Grégoire Mignot, et al.
Gut|October 20, 2009
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerBoris Guiu, Jean Michel Petit, Franck Bonnetain, et al.
Breast (Edinburgh, Scotland)|June 26, 2021
Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-studyAriane Mamguem Kamga, Oumar Billa, Sylvain Ladoire, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Bulletin Du Cancer|November 9, 2019
[Strategies in case of metastatic sentinel lymph node in breast cancer]Hélène Costaz, Magali Rouffiac, Delphine Boulle, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsFrançois Ghiringhelli, Cedric Menard, Pierre Emmanuel Puig, et al.
British Journal of Cancer|July 18, 2020
Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based studyJulien Simon, Marie Chaix, Oumar Billa, et al.
Cancers|June 19, 2024
HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular EntityCéline André, Aurélie Bertaut, Sylvain Ladoire, et al.
Oncotarget|January 30, 2016
Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?Valentin Derangère, Jean David Fumet, Romain Boidot, et al.
Cancers|November 11, 2022
Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune CheckpointsDelphine Hudry, Solenn Le Guellec, Samuel Meignan, et al.
BMC Infectious Diseases|December 6, 2008
Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patientsPierre Emmanuel Charles, Sylvain Ladoire, Aurélie Snauwaert, et al.
Breast Cancer Research and Treatment|March 16, 2010
Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapySylvain Ladoire, Laurent Arnould, Grégoire Mignot, et al.
Gut|October 20, 2009
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerBoris Guiu, Jean Michel Petit, Franck Bonnetain, et al.
Breast (Edinburgh, Scotland)|June 26, 2021
Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-studyAriane Mamguem Kamga, Oumar Billa, Sylvain Ladoire, et al.
Pageof 17